Getting everyone to agree on gene signatures for murine macrophage polarization in vitro
2024-01-01 Colombo, Giorgia; Pessolano, Emanuela; Talmon, Maria; Genazzani, Armando A.; Kunderfranco, Paolo
HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis
2020-01-01 Schettini, F; Pascual, T; Conte, B; Chic, N; BRASÓ-MARISTANY, F; Galván, P; Martínez, O; Adamo, B; Vidal, M; Muñoz, M; FERNÁNDEZ-MARTINEZ, A; Rognoni, C; Griguolo, G; Guarneri, V; Conte, Pf; Locci, M; Brase, Jc; GONZALEZ-FARRE, B; Villagrasa, P; DE PLACIDO, S; Schiff, R; Veeraraghavan, J; Rimawi, Mf; Osborne, Ck; Pernas, S; Perou, Cm; Carey, La; Prat, A
Management of young women with early breast cancer
2018-01-01 Poggio, F; Lambertini, M; Bighin, C; Conte, B; Blondeaux, E; D'Alonzo, A; Dellepiane, C; Boccardo, F; DEL MASTRO, L
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer
2021-01-01 Schettini, F; Chic, N; BRASÓ-MARISTANY, F; Paré, L; Pascual, T; Conte, B; MARTÍNEZ-SÁEZ, O; Adamo, B; Vidal, M; Barnadas, E; FERNÁNDEZ-MARTÍNEZ, A; GONZÁLEZ-FARRÉ, B; Sanfeliu, E; Cejalvo, Jm; Perrone, G; Sabarese, G; Zalfa, F; Peg, V; Fasani, R; Villagrasa, P; Gavilá, J; Barrios, Ch; Lluch, A; Martín, M; Locci, M; DE PLACIDO, S; Prat, A
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study
2020-01-01 Blondeaux, Eva; Lambertini, Matteo; Michelotti, Andrea; Conte, Benedetta; Benasso, Marco; Dellepiane, Chiara; Bighin, Claudia; Pastorino, Simona; Levaggi, Alessia; D’ Alonzo, Alessia; Poggio, Francesca; Buzzatti, Giulia; Molinelli, Chiara; Fregatti, Piero; Bertoglio, Sergio; Boccardo, Francesco; Del Mastro, Lucia
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak
2020-01-01 Tagliamento, M; Spagnolo, F; Poggio, F; Soldato, D; Conte, B; Ruelle, T; Barisione, E; DE MARIA, A; DEL MASTRO, L; DI MAIO, M; Lambertini, M
Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial
2020-01-01 Lambertini, M; Poggio, F; Bruzzone, M; Conte, B; Bighin, C; DE AZAMBUJA, E; Giuliano, M; DE LAURENTIIS, M; Cognetti, F; Fabi, A; Bisagni, G; Durando, A; Turletti, A; Urracci, Y; Garrone, O; Puglisi, F; Montemurro, F; Cepp, I M; DEL MASTRO, L
De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence
2022-01-01 Conte, B.; Soldato, D.; Razeti, M. G.; Fregatti, P.; de Azambuja, E.; Schettini, F.; Prat, A.; Del Mastro, L.; Lambertini, M.
SNPs of aromatase predict long-term survival and aromatase inhibitor toxicity in patients with early breast cancer: a biomarker analysis of the GIM4 and GIM5 trials
2023-01-01 Conte, Benedetta; Boni, Luca; Bisagni, Giancarlo; Durando, Antonio; Sanna, Giovanni; Gori, Stefania; Garrone, Ornella; Tamberi, Stefano; De Placido, Sabino; Schettini, Francesco; Pazzola, Antonio; Ponzone, Riccardo; Montemurro, Filippo; Lunardi, Gianluigi; Notaro, Rosario; De Angioletti, Maria; Turletti, Anna; Mansutti, Mauro; Puglisi, Fabio; Frassoldati, Antonio; Porpiglia, Mauro; Fabi, Alessandra; Generali, Daniele; Scognamiglio, Giovanni; Rossi, Maura; Brasó Maristany, Fara; Prat, Aleix; Cardinali, Barbara; Piccioli, Patrizia; Serra, Martina; Lastraioli, Sonia; Bighin, Claudia; Poggio, Francesca; Lambertini, Matteo; Del Mastro, Lucia
Luteinizing hormone-releasing hormone analogs in combination with tamoxifen for the adjuvant treatment of premenopausal women with hormone receptor-positive breast cancer
2017-01-01 Conte, B; Poggio, F; DEL MASTRO, L
Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: exploratory analysis of the GIM2 trial
2020-01-01 Lambertini, Matteo; Poggio, Francesca; Bruzzone, Marco; Conte, Benedetta; Bighin, Claudia; de Azambuja, Evandro; Giuliano, Mario; De Laurentiis, Michele; Cognetti, Francesco; Fabi, Alessandra; Bisagni, Giancarlo; Durando, Antonio; Turletti, Anna; Urracci, Ylenia; Garrone, Ornella; Puglisi, Fabio; Montemurro, Filippo; Ceppi, Marcello; Del Mastro, Lucia
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study
2020-01-01 Conte, B; Fabi, A; Poggio, F; Blondeaux, E; Dellepiane, C; D'Alonzo, A; Buono, G; Arpino, G; Magri, V; Naso, G; Presti, D; Mura, S; Fontana, A; Cognetti, F; Molinelli, C; Pastorino, S; Bighin, C; Miglietta, L; Boccardo, F; Lambertini, M; Del, Mastro
Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy
2021-01-01 MARTÍNEZ-SÁEZ, O; Pascual, T; BRASÓ-MARISTANY, F; Chic, N; GONZÁLEZ-FARRÉ, B; Sanfeliu, E; Rodríguez, A; Martínez, D; Galván, P; Rodríguez, Ab; Schettini, F; Conte, B; Vidal, M; Adamo, B; Martínez, A; Muñoz, M; Moreno, R; Villagrasa, P; Salvador, F; Ciruelos, Em; Faull, I; Odegaard, Ji; Prat, A
Frequency and spectrum of PIK3CA somatic mutations in breast cancer
2020-01-01 MARTÍNEZ-SÁEZ, O; Chic, N; Pascual, T; Adamo, B; Vidal, M; GONZÁLEZ-FARRÉ, B; Sanfeliu, E; Schettini, F; Conte, B; BRASÓ-MARISTANY, F; Rodríguez, A; Martínez, D; Galván, P; Rodríguez, Ab; Martinez, A; Muñoz, M; Prat, A
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study
2019-01-01 Conte, Benedetta; Fabi, Alessandra; Poggio, Francesca; Blondeaux, Eva; Dellepiane, Chiara; D'Alonzo, Alessia; Buono, Giuseppe; Arpino, Grazia; Magri, Valentina; Naso, Giuseppe; Presti, Daniele; Mura, Silvia; Fontana, Andrea; Cognetti, Francesco; Molinelli, Chiara; Pastorino, Simona; Bighin, Claudia; Miglietta, Loredana; Boccardo, Francesco; Lambertini, Matteo; Del Mastro, Lucia
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study
2020-01-01 Blondeaux, E; Lambertini, M; Michelotti, A; Conte, B; Benasso, M; Dellepiane, C; Bighin, C; Pastorino, S; Levaggi, A; Alonzo, A; Poggio, F; Buzzatti, G; Molinelli, C; Fregatti, P; Bertoglio, S; Boccardo, F; DEL MASTRO, L
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial
2022-01-01 Conte, B; Montemurro, F; Levaggi, A; Blondeaux, E; Molinelli, C; Cardinali, B; Poggio, F; Buzzatti, G; Bighin, C; Lambertini, M; DEL MASTRO, L
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis
2018-01-01 Poggio, F; Bruzzone, M; Ceppim, ; Conte, B; Martel, S; Maurer, C; Tagliamento, M; Viglietti, G; DEL MASTRO, L; DE AZAMBUJA, E; Lambertini, M
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1
2023-01-01 BRASÓ-MARISTANY, F; Griguolo, G; Chic, N; Pascual, T; Paré, L; Maues, J; Galván, P; Dieci, Mv; Miglietta, F; Giarratano, T; MARTÍNEZ-SÁEZ, O; MARÍN-AGUILERA, M; Schettini, F; Conte, B; Angelats, L; Vidal, M; Adamo, B; Muñoz, M; Sanfeliu, E; González, B; Vivancos, A; Villagrasa, P; Parker, Js; Perou, Cm; Conte, P; Prat, A; Guarneri, V
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer
2022-01-01 Prat, A; Guarneri, V; Pascual, T; BRASÓ-MARISTANY, F; Sanfeliu, E; Paré, L; Schettini, F; Martínez, D; Jares, P; Griguolo, G; Dieci, Mv; Cortés, J; LLOMBART-CUSSAC, A; Conte, B; MARÍN-AGUILERA, M; Chic, N; PUIG-BUTILLÉ, Ja; Martínez, A; Galván, P; Tsai, Yh; GONZÁLEZ-FARRÉ, B; Mira, A; Vivancos, A; Villagrasa, P; Parker, Js; Conte, P; Perou, Cm
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Getting everyone to agree on gene signatures for murine macrophage polarization in vitro | 1-gen-2024 | Colombo, Giorgia; Pessolano, Emanuela; Talmon, Maria; Genazzani, Armando A.; Kunderfranco, Paolo | |
HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis | 1-gen-2020 | Schettini, F; Pascual, T; Conte, B; Chic, N; BRASÓ-MARISTANY, F; Galván, P; Martínez, O; Adamo, B; Vidal, M; Muñoz, M; FERNÁNDEZ-MARTINEZ, A; Rognoni, C; Griguolo, G; Guarneri, V; Conte, Pf; Locci, M; Brase, Jc; GONZALEZ-FARRE, B; Villagrasa, P; DE PLACIDO, S; Schiff, R; Veeraraghavan, J; Rimawi, Mf; Osborne, Ck; Pernas, S; Perou, Cm; Carey, La; Prat, A | |
Management of young women with early breast cancer | 1-gen-2018 | Poggio, F; Lambertini, M; Bighin, C; Conte, B; Blondeaux, E; D'Alonzo, A; Dellepiane, C; Boccardo, F; DEL MASTRO, L | |
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer | 1-gen-2021 | Schettini, F; Chic, N; BRASÓ-MARISTANY, F; Paré, L; Pascual, T; Conte, B; MARTÍNEZ-SÁEZ, O; Adamo, B; Vidal, M; Barnadas, E; FERNÁNDEZ-MARTÍNEZ, A; GONZÁLEZ-FARRÉ, B; Sanfeliu, E; Cejalvo, Jm; Perrone, G; Sabarese, G; Zalfa, F; Peg, V; Fasani, R; Villagrasa, P; Gavilá, J; Barrios, Ch; Lluch, A; Martín, M; Locci, M; DE PLACIDO, S; Prat, A | |
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study | 1-gen-2020 | Blondeaux, Eva; Lambertini, Matteo; Michelotti, Andrea; Conte, Benedetta; Benasso, Marco; Dellepiane, Chiara; Bighin, Claudia; Pastorino, Simona; Levaggi, Alessia; D’ Alonzo, Alessia; Poggio, Francesca; Buzzatti, Giulia; Molinelli, Chiara; Fregatti, Piero; Bertoglio, Sergio; Boccardo, Francesco; Del Mastro, Lucia | |
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak | 1-gen-2020 | Tagliamento, M; Spagnolo, F; Poggio, F; Soldato, D; Conte, B; Ruelle, T; Barisione, E; DE MARIA, A; DEL MASTRO, L; DI MAIO, M; Lambertini, M | |
Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial | 1-gen-2020 | Lambertini, M; Poggio, F; Bruzzone, M; Conte, B; Bighin, C; DE AZAMBUJA, E; Giuliano, M; DE LAURENTIIS, M; Cognetti, F; Fabi, A; Bisagni, G; Durando, A; Turletti, A; Urracci, Y; Garrone, O; Puglisi, F; Montemurro, F; Cepp, I M; DEL MASTRO, L | |
De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence | 1-gen-2022 | Conte, B.; Soldato, D.; Razeti, M. G.; Fregatti, P.; de Azambuja, E.; Schettini, F.; Prat, A.; Del Mastro, L.; Lambertini, M. | |
SNPs of aromatase predict long-term survival and aromatase inhibitor toxicity in patients with early breast cancer: a biomarker analysis of the GIM4 and GIM5 trials | 1-gen-2023 | Conte, Benedetta; Boni, Luca; Bisagni, Giancarlo; Durando, Antonio; Sanna, Giovanni; Gori, Stefania; Garrone, Ornella; Tamberi, Stefano; De Placido, Sabino; Schettini, Francesco; Pazzola, Antonio; Ponzone, Riccardo; Montemurro, Filippo; Lunardi, Gianluigi; Notaro, Rosario; De Angioletti, Maria; Turletti, Anna; Mansutti, Mauro; Puglisi, Fabio; Frassoldati, Antonio; Porpiglia, Mauro; Fabi, Alessandra; Generali, Daniele; Scognamiglio, Giovanni; Rossi, Maura; Brasó Maristany, Fara; Prat, Aleix; Cardinali, Barbara; Piccioli, Patrizia; Serra, Martina; Lastraioli, Sonia; Bighin, Claudia; Poggio, Francesca; Lambertini, Matteo; Del Mastro, Lucia | |
Luteinizing hormone-releasing hormone analogs in combination with tamoxifen for the adjuvant treatment of premenopausal women with hormone receptor-positive breast cancer | 1-gen-2017 | Conte, B; Poggio, F; DEL MASTRO, L | |
Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: exploratory analysis of the GIM2 trial | 1-gen-2020 | Lambertini, Matteo; Poggio, Francesca; Bruzzone, Marco; Conte, Benedetta; Bighin, Claudia; de Azambuja, Evandro; Giuliano, Mario; De Laurentiis, Michele; Cognetti, Francesco; Fabi, Alessandra; Bisagni, Giancarlo; Durando, Antonio; Turletti, Anna; Urracci, Ylenia; Garrone, Ornella; Puglisi, Fabio; Montemurro, Filippo; Ceppi, Marcello; Del Mastro, Lucia | |
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study | 1-gen-2020 | Conte, B; Fabi, A; Poggio, F; Blondeaux, E; Dellepiane, C; D'Alonzo, A; Buono, G; Arpino, G; Magri, V; Naso, G; Presti, D; Mura, S; Fontana, A; Cognetti, F; Molinelli, C; Pastorino, S; Bighin, C; Miglietta, L; Boccardo, F; Lambertini, M; Del, Mastro | |
Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy | 1-gen-2021 | MARTÍNEZ-SÁEZ, O; Pascual, T; BRASÓ-MARISTANY, F; Chic, N; GONZÁLEZ-FARRÉ, B; Sanfeliu, E; Rodríguez, A; Martínez, D; Galván, P; Rodríguez, Ab; Schettini, F; Conte, B; Vidal, M; Adamo, B; Martínez, A; Muñoz, M; Moreno, R; Villagrasa, P; Salvador, F; Ciruelos, Em; Faull, I; Odegaard, Ji; Prat, A | |
Frequency and spectrum of PIK3CA somatic mutations in breast cancer | 1-gen-2020 | MARTÍNEZ-SÁEZ, O; Chic, N; Pascual, T; Adamo, B; Vidal, M; GONZÁLEZ-FARRÉ, B; Sanfeliu, E; Schettini, F; Conte, B; BRASÓ-MARISTANY, F; Rodríguez, A; Martínez, D; Galván, P; Rodríguez, Ab; Martinez, A; Muñoz, M; Prat, A | |
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study | 1-gen-2019 | Conte, Benedetta; Fabi, Alessandra; Poggio, Francesca; Blondeaux, Eva; Dellepiane, Chiara; D'Alonzo, Alessia; Buono, Giuseppe; Arpino, Grazia; Magri, Valentina; Naso, Giuseppe; Presti, Daniele; Mura, Silvia; Fontana, Andrea; Cognetti, Francesco; Molinelli, Chiara; Pastorino, Simona; Bighin, Claudia; Miglietta, Loredana; Boccardo, Francesco; Lambertini, Matteo; Del Mastro, Lucia | |
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study | 1-gen-2020 | Blondeaux, E; Lambertini, M; Michelotti, A; Conte, B; Benasso, M; Dellepiane, C; Bighin, C; Pastorino, S; Levaggi, A; Alonzo, A; Poggio, F; Buzzatti, G; Molinelli, C; Fregatti, P; Bertoglio, S; Boccardo, F; DEL MASTRO, L | |
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial | 1-gen-2022 | Conte, B; Montemurro, F; Levaggi, A; Blondeaux, E; Molinelli, C; Cardinali, B; Poggio, F; Buzzatti, G; Bighin, C; Lambertini, M; DEL MASTRO, L | |
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis | 1-gen-2018 | Poggio, F; Bruzzone, M; Ceppim, ; Conte, B; Martel, S; Maurer, C; Tagliamento, M; Viglietti, G; DEL MASTRO, L; DE AZAMBUJA, E; Lambertini, M | |
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1 | 1-gen-2023 | BRASÓ-MARISTANY, F; Griguolo, G; Chic, N; Pascual, T; Paré, L; Maues, J; Galván, P; Dieci, Mv; Miglietta, F; Giarratano, T; MARTÍNEZ-SÁEZ, O; MARÍN-AGUILERA, M; Schettini, F; Conte, B; Angelats, L; Vidal, M; Adamo, B; Muñoz, M; Sanfeliu, E; González, B; Vivancos, A; Villagrasa, P; Parker, Js; Perou, Cm; Conte, P; Prat, A; Guarneri, V | |
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer | 1-gen-2022 | Prat, A; Guarneri, V; Pascual, T; BRASÓ-MARISTANY, F; Sanfeliu, E; Paré, L; Schettini, F; Martínez, D; Jares, P; Griguolo, G; Dieci, Mv; Cortés, J; LLOMBART-CUSSAC, A; Conte, B; MARÍN-AGUILERA, M; Chic, N; PUIG-BUTILLÉ, Ja; Martínez, A; Galván, P; Tsai, Yh; GONZÁLEZ-FARRÉ, B; Mira, A; Vivancos, A; Villagrasa, P; Parker, Js; Conte, P; Perou, Cm |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista32008
- 4 Contributo in Atti di Convegno ...1
Data di pubblicazione
- In corso di stampa61
- 2020 - 20256443
- 2010 - 201912491
- 2000 - 20097143
- 1990 - 19994148
- 1980 - 19891467
- 1970 - 1979232
- 1962 - 196924
Rivista
- PHYSICS LETTERS. SECTION B722
- JOURNAL OF HIGH ENERGY PHYSICS403
- THE EUROPEAN PHYSICAL JOURNAL. C,...281
- PHYSICAL REVIEW LETTERS260
- PHYSICAL REVIEW D195
- JOURNAL OF HIGH ENERGY PHYSICS191
- PLOS ONE171
- BLOOD163
- THE JOURNAL OF CRANIOFACIAL SURGERY143
- NUCLEAR INSTRUMENTS & METHODS IN ...139
Keyword
- Humans1398
- Female737
- Male584
- Middle Aged443
- Adult398
- Aged394
- COVID-19283
- Italy270
- Animals212
- Treatment Outcome190
Lingua
- eng21383
- ita4903
- fre240
- spa151
- ger55
- rus27
- und26
- por16
- lat15
- grc6
Accesso al fulltext
- no fulltext20224
- reserved6416
- open3406
- restricted1879
- partially open57
- embargoed22
- mixed5